Showing results (11-20 of 22) with videos related to
Sort By:
Pageof 3
Clinical Biochemistry|June 1, 1990
Low concentration galactose determination in plasma adapted to the Cobas-BioM R Pudek, A Jamani, V Bernstein, et al.The Journal of Chemical Physics|June 3, 2019
Emission of velocity-correlated clusters in fullerene-solid single collision and diagnostics of the impact energized subsurface nanovolumeE Armon, E Zemel, A Bekkerman, et al.The Annals of Thoracic Surgery|February 1, 1991
Diagnosis of poststernotomy infection: comparison of three means of assessmentD A Browdie, R V Bernstein, R Agnew, et al.Circulation|January 7, 1998
Sphygmomanometrically determined pulse pressure is a powerful independent predictor of recurrent events after myocardial infarction in patients with impaired left ventricular function. SAVE investigators. Survival and Ventricular EnlargementG F Mitchell, L A Moyé, E Braunwald, et al.The Canadian Journal of Cardiology|July 1, 1994
Diagnosis and management of heart failure. Canadian Cardiovascular SocietyD E Johnstone, A Abdulla, J M Arnold, et al.The New England Journal of Medicine|March 18, 1993
A comparison of management patterns after acute myocardial infarction in Canada and the United States. The SAVE investigatorsJ L Rouleau, L A Moyé, M A Pfeffer, et al.Circulation|January 20, 1999
Reduction of stroke incidence after myocardial infarction with pravastatin: the Cholesterol and Recurrent Events (CARE) study. The Care InvestigatorsJ F Plehn, B R Davis, F M Sacks, et al.Sovremennye Tekhnologii V Meditsine|February 13, 2025
Identification of Diagnostic Schizophrenia Biomarkers Based on the Assessment of Immune and Systemic Inflammation Parameters Using Machine Learning ModelingI K Malashenkova, S A Krynskiy, D P Ogurtsov, et al.The Canadian Journal of Cardiology|February 1, 1997
Angiotensin-converting enzyme inhibition in myocardial infarction--Part 2: Clinical issues and controversiesV F Huckell, V Bernstein, R Crowell, et al.The Canadian Journal of Cardiology|February 1, 1997
Angiotensin-converting enzyme inhibition in myocardial infarction--Part 1: Clinical dataV F Huckell, V Bernstein, J A Cairns, et al.Pageof 3